Lipocine announces deletion of unauthorized changes to company's website

Salt lake city, dec. 8, 2020 /prnewswire/ -- lipocine inc. (nasdaq: lpcn), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced that an independent contractor posted on lipocine's website (www.lipocine.com), without authorization from...

LPCN Ratings Summary

LPCN Quant Ranking